Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学MET Exon 14 Skipping Alterations

D. Ross Camidge

MD, PhD

🏢University of Colorado Cancer Center🌐USA

Joyce Zeff Chair in Lung Cancer Research

80
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ross Camidge holds the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado and has made important contributions to MET-targeted therapy. His research on MET amplification as a bypass resistance mechanism has influenced combination therapy design. He is a thought leader in molecular subtyping and treatment sequencing in NSCLC.

Share:

🧪Research Fields 研究领域

MET exon 14 skipping
ALK fusions
Drug resistance
Thoracic oncology
Translational research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 D. Ross Camidge 的研究动态

Follow D. Ross Camidge's research updates

留下邮箱,当我们发布与 D. Ross Camidge(University of Colorado Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment